EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION
Providing grants for the advancement of education in the field of cancer research
Objects
THE OBJECT OF THE CIO IS FOR THE PUBLIC BENEFIT TO ADVANCE EDUCATION BY THE PROVISION OF FINANCIAL SUPPORT TO ASSIST INDIVIDUALS IN FURTHERING THEIR POST GRADUATE STUDIES AND RESEARCH IN THE FIELD OF CANCER RELATED STUDIES AND RESEARCH AT RECOGNIZED UNIVERSITIES, COLLEGES, HOSPITALS, RESEARCH ORGANISATIONS AND SIMILAR INSTITUTIONS IN THE UNITED KINGDOM AND ELSEWHERE AND TO PROVIDE FINANCIAL SUPPORT TO THOSE INSTITUTIONS IN CONNECTION WITH CANCER RELATED STUDIES AND RESEARCH.
Financial health, per its FY2024 accounts
The accounts state that unrestricted funds decreased from £19,594 to £2,520 due to charitable expenditure exceeding income. The trustees confirm the charity has adequate resources to continue in operational existence for the foreseeable future.
What the accounts disclose
Funders the charity credits
- Novibet’s Giant Heart Initiative
Trustees
- Spiros Giamaschair
- Christopher Christou
- Menelaos Giamas
- Piero Soteriou
- Robert Soteriou
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £15k | £20k |
| 31/12/2024 | £32k | £49k |
| 31/12/2023 | £15k | £23k |
| 31/12/2022 | £3k | £25k |
| 31/12/2021 | £65k | £16k |
Common questions
Is EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION financially healthy?
Per its FY2024 accounts: The accounts state that unrestricted funds decreased from £19,594 to £2,520 due to charitable expenditure exceeding income. The trustees confirm the charity has adequate resources to continue in operational existence for the foreseeable future. Its FY2024 accounts were independently examined.